Microbot Medical (MBOT) Competitors $3.13 +0.09 (+2.96%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$3.10 -0.03 (-0.96%) As of 06:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBOT vs. DCTH, BFLY, TMCI, RXST, SNWV, NPCE, STIM, CATX, CLPT, and OMShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Delcath Systems (DCTH), Butterfly Network (BFLY), Treace Medical Concepts (TMCI), RxSight (RXST), Sanuwave Health (SNWV), NeuroPace (NPCE), Neuronetics (STIM), Perspective Therapeutics (CATX), ClearPoint Neuro (CLPT), and Outset Medical (OM). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Its Competitors Delcath Systems Butterfly Network Treace Medical Concepts RxSight Sanuwave Health NeuroPace Neuronetics Perspective Therapeutics ClearPoint Neuro Outset Medical Delcath Systems (NASDAQ:DCTH) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk. Do institutionals and insiders hold more shares of DCTH or MBOT? 61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 17.4% of Delcath Systems shares are held by company insiders. Comparatively, 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, DCTH or MBOT? Delcath Systems has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Do analysts prefer DCTH or MBOT? Delcath Systems currently has a consensus target price of $24.50, suggesting a potential upside of 134.00%. Microbot Medical has a consensus target price of $9.00, suggesting a potential upside of 187.54%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than Delcath Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer DCTH or MBOT? In the previous week, Delcath Systems had 15 more articles in the media than Microbot Medical. MarketBeat recorded 19 mentions for Delcath Systems and 4 mentions for Microbot Medical. Delcath Systems' average media sentiment score of 0.23 beat Microbot Medical's score of -0.18 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Microbot Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has better valuation & earnings, DCTH or MBOT? Microbot Medical has lower revenue, but higher earnings than Delcath Systems. Microbot Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$37.21M9.84-$26.39M$0.05209.40Microbot MedicalN/AN/A-$11.44M-$0.58-5.40 Is DCTH or MBOT more profitable? Delcath Systems has a net margin of 3.18% compared to Microbot Medical's net margin of 0.00%. Delcath Systems' return on equity of 6.91% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems3.18% 6.91% 5.80% Microbot Medical N/A -76.27%-67.54% SummaryDelcath Systems beats Microbot Medical on 11 of the 14 factors compared between the two stocks. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$138.46M$7.00B$5.61B$9.84BDividend YieldN/A1.30%4.61%4.07%P/E Ratio-5.4025.4830.2725.74Price / SalesN/A73.48459.75115.79Price / CashN/A21.9738.2159.48Price / Book4.675.388.846.15Net Income-$11.44M$176.29M$3.25B$265.06M7 Day Performance1.29%3.21%3.72%2.60%1 Month Performance26.21%1.49%5.86%2.83%1 Year Performance213.00%10.20%30.25%25.58% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical1.6432 of 5 stars$3.13+3.0%$9.00+187.5%+216.2%$138.46MN/A-5.4020News CoverageEarnings ReportDCTHDelcath Systems2.6732 of 5 stars$11.27+6.4%$24.00+113.0%+42.3%$368.81M$37.21M0.0060Short Interest ↑BFLYButterfly Network2.5225 of 5 stars$1.43+1.8%$3.50+145.6%+50.4%$346.20M$82.06M0.00460Gap UpTMCITreace Medical Concepts2.5218 of 5 stars$5.61+5.1%$10.52+87.5%+27.1%$335.83M$209.36M0.00250RXSTRxSight1.502 of 5 stars$7.92+1.5%$17.50+121.0%-83.9%$316.97M$139.93M0.00220Trending NewsShort Interest ↑SNWVSanuwave Health2.5198 of 5 stars$35.49-2.1%$49.00+38.1%N/A$310.55M$32.63M-7.7940Earnings ReportGap UpNPCENeuroPace3.1616 of 5 stars$8.93-0.7%$17.00+90.4%+33.4%$294.86M$79.91M0.00170News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionSTIMNeuronetics2.4458 of 5 stars$4.66+5.4%$5.50+18.0%+329.0%$292.22M$74.89M0.00180Gap UpCATXPerspective Therapeutics1.6841 of 5 stars$3.89+5.7%$12.56+222.8%-70.8%$288.75MN/A0.0070CLPTClearPoint Neuro1.7282 of 5 stars$10.53+5.3%$19.67+86.8%+18.8%$279.89M$31.39M0.00110Earnings ReportOMOutset Medical1.7737 of 5 stars$14.16-5.9%$29.50+108.3%+3.2%$266.54M$113.69M0.00520Gap Down Related Companies and Tools Related Companies Delcath Systems Alternatives Butterfly Network Alternatives Treace Medical Concepts Alternatives RxSight Alternatives Sanuwave Health Alternatives NeuroPace Alternatives Neuronetics Alternatives Perspective Therapeutics Alternatives ClearPoint Neuro Alternatives Outset Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBOT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access